Highly rated in
Highly rated in
Check Dr. David G. Mutch's experience treating your condition:
About Dr. David G. Mutch

David Mutch is a Gynecologic Oncologist and an Oncologist in Saint Louis, Missouri. Mutch has been practicing medicine for over 42 years and is highly rated in 34 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Oophorectomy. He is licensed to treat patients in Missouri. Mutch is currently accepting new patients.

His clinical research consists of co-authoring 256 peer reviewed articles and participating in 30 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. David G. Mutch it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. David G. Mutch accepts the following insurance:

  •  Ambetter
  •  Cigna
  •  Cox Health

Call to see if your plan is accepted.
4921 Parkview Pl, Saint Louis, MO 63110
Other Locations
3023 N Ballas Rd, St. Louis, MO 63131
Background & Education
Graduate Institution
Washington University School Of Medicine, 1980
Gynecologic Oncology
Obstetrics & Gynecology in MO
Hospital Affiliations
Anderson Hospital
St Louis Childrens Hospital
Missouri Baptist Medical Center
HSHS St Elizabeths Hospital
Southeast Hospital
Memorial Hospital Belleville
Alton Memorial Hospital
Mercy Hospital St Louis
Barnes-Jewish Hospital
HSHS St Josephs Hospital - Breese
Barnes-Jewish West County Hospital
St Lukes Hospital
SIH Memorial Hospital Of Carbondale
SSM Health Good Samaritan Hospital - Mt Vernon
Jersey Community Hospital
Missouri Delta Medical Center
Progress West Hospital
Memorial Hospital
Barnes-Jewish St Peters Hospital
SIH Herrin Hospital
Parkland Health Center - Farmington
Christian Hospital
SIH St Joseph Memorial Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

29 Clinical Trials

A Phase I Study of PD-1 Inhibition With TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer (DeCRESCEndo)
Phase II Trial of Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
Phase II Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian and Primary Peritoneal Carcinoma
Does Antibiotic Prophylaxis Reduce Wound Complications After Vulvar Excision of Premalignant Lesions: A Double-Blinded Randomized Controlled Trial
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
Implementation and Evaluation of Psychological Services Integration in Gynecological Oncology Clinics
Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rates: The BASICS Trial
A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex Cord-Stromal Tumors of the Ovary
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Phase IB Study of Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients With Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer
Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary
Phase II Study of Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Phase II Randomized Trial of Nivolumab With or Without Ipilimumab in Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase II Trial of Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in the Front-line Treatment of Patients With Advanced Stage Ovarian Carcinoma
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate: The BASICS Trial
A Phase II Trial Evaluating Cisplatin (NSC #119875) and Gemcitabine (NSC #613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Vulva (NCT #01595061)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Phase I Trial of the Combination of the PARP Inhibitor ABT-888 With Intraperitoneal Floxuridine (FUDR) in Epithelial Ovarian, Primary Peritoneal and Fallopian Tube Cancers
Immunotherapy With MK-3475 in Surgically Resectable Endometrial Carcinoma
A Phase II Randomized Trial of Olaparib Versus Olaparib Plus Tremelimumab in Platinum-Sensitive Recurrent Ovarian Cancer
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
View 25 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors